openPR Logo
Press release

Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Will Reach A Revised Size Of Us$ 6835.3 Million By 2028, Growing At A Cagr Of 10.3% During 2022-2028

11-02-2022 04:26 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: QY Research, Inc

Global Dermatophytic Onychomycosis Therapeutics (DOT) Market

Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs. However, adverse effects associated with anti-fungal drugs and lack of awareness about dermatophytic onychomycosis in Asia Pacific, Middle East and Africa, and Latin America are expected to impede growth of the global dermatophytic onychomycosis therapeutics market.

Market Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Dermatophytic Onychomycosis Therapeutics (DOT) estimated at US$ 3789.6 million in the year 2022, is projected to reach a revised size of US$ 6835.3 million by 2028, growing at a CAGR of 10.3% during the forecast period 2022-2028.

The global dermatophytic onychomycosis therapeutics market is anticipated to expand at a healthy CAGR during the forecast period. By product type, the market is segmented into Nail paint and tablet, which is again sub-divided into prescription (Rx) and over-the-counter (OTC) sub segments. The nail paint segment is expected to contribute a maximum share to the global dermatophytic onychomycosis therapeutics market. By treatment, the market is segmented into topical and oral therapy. Among these, the topical segment is anticipated to be dominant throughout the forecast period and projected to account for about 70% share of the total global dermatophytic onychomycosis market revenue by 2025.

Los Angeles, United States November 2022,- The research study presented here is a brilliant compilation of different types of analysis of critical aspects of the global Dermatophytic Onychomycosis Therapeutics (DOT) market. It sheds light on how the global Dermatophytic Onychomycosis Therapeutics (DOT) market is expected to grow during the course of the forecast period. With SWOT analysis and Porter's Five Forces analysis, it gives a deep explanation of the strengths and weaknesses of the global Dermatophytic Onychomycosis Therapeutics (DOT) market and the different players operating therein. The authors of the report have also provided qualitative and quantitative analyses of several microeconomic and macroeconomic factors impacting the global Dermatophytic Onychomycosis Therapeutics (DOT) market. In addition, the research study helps to understand the changes in the industry supply chain, manufacturing process and cost, sales scenarios, and dynamics of the global Dermatophytic Onychomycosis Therapeutics (DOT) market.

Request to Download PDF Sample Copy of Report:  https://www.qyresearch.com/sample-form/form/5172547/Global-Dermatophytic-Onychomycosis-Therapeutics-DOT-Market-Report-History-and-Forecast-2017-2028-Breakdown-Data-by-Companies-Key-Regions-Types-and-Application

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dermatophytic Onychomycosis Therapeutics (DOT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dermatophytic Onychomycosis Therapeutics (DOT).

The Dermatophytic Onychomycosis Therapeutics (DOT) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Dermatophytic Onychomycosis Therapeutics (DOT) market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dermatophytic Onychomycosis Therapeutics (DOT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

Market Segmentation

This report covers the Dermatophytic Onychomycosis Therapeutics (DOT) segments by manufacturers, by type, by application, by region and country, and provides market size and CAGR for the history and forecast period (2017-2022, 2023-2028), considering 2021 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

By Company

Galderma

Bausch Health

Novartis

Pfizer

Janssen

Dermatophytic Onychomycosis Therapeutics (DOT) Segment by Type

Topical

Oral Therapy

Dermatophytic Onychomycosis Therapeutics (DOT) Segment by Application

Hospitals

Dermatology And Podiatry Clinics

Independent Pharmacies

Mail Order Pharmacies

Drug Stores

Dermatophytic Onychomycosis Therapeutics (DOT) Segment by Region

North America (USA, Canada, Mexico)

Europe (Germany, the U.K., France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East and Africa (Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA)

Reasons to Buy This Report

Informative and detailed data, historical and forecast revenue data, which is analyzed to tell you why your market is set to change. Provision of market value (USD million) data for each segment and sub-segment.

This report will help stakeholders to understand the global industry status and trends of Dermatophytic Onychomycosis Therapeutics (DOT) and provides them with information on key market drivers, restraints, challenges, and opportunities. This enables you to anticipate market changes to remain ahead of your competitors.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition. This concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly.

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Dermatophytic Onychomycosis Therapeutics (DOT) industry. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Core Chapters

Chapter One: Introduces the

Report Scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2017-2022, 2023-2028). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter Two: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter Three: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter Four: Detailed analysis of Dermatophytic Onychomycosis Therapeutics (DOT) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.

Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter Twelve: Research Finding/Conclusion

Enquire for customization in Report Dermatophytic Onychomycosis Therapeutics (DOT) : https://www.qyresearch.com/customize-request/form/5172547/Global-Dermatophytic-Onychomycosis-Therapeutics-DOT-Market-Report-History-and-Forecast-2017-2028-Breakdown-Data-by-Companies-Key-Regions-Types-and-Application

 Contact Us

 QY RESEARCH, INC.

17890 CASTLETON STREET

SUITE 369, CITY OF INDUSTRY

CA - 91748, UNITED STATES OF AMERICA

+1 626 539 9760 / +91 8669986909

hitesh@qyresearch.com / enquiry@qyresearch.com

About Us

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from the huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become a brand of quality assurance in the consulting industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Dermatophytic Onychomycosis Therapeutics (DOT) Market Will Reach A Revised Size Of Us$ 6835.3 Million By 2028, Growing At A Cagr Of 10.3% During 2022-2028 here

News-ID: 2789569 • Views:

More Releases from QY Research, Inc

Global High Pressure Commercial Toilet Market Insights - Industry Share, Sales Projections, and Demand Outlook 2024-2030-KRBL,LT FOODS,REI Agro
Global High Pressure Commercial Toilet Market Insights - Industry Share, Sales P …
High Pressure Commercial Toilet also means pressure-flushing toilets. Pressure-flushing toilets are especially common in cities in the U.S. The ceramic tank is not used as a water tank. It holds a plastic pressure vessel of maybe one-third to one-half the ceramic tank"s volume. That pressure tank contains a sealed air bladder. When the tank is filled from the water supply line, the tank fills with water until the air bladder
Global Twin-Screw Pumps Market Insights - Industry Share, Sales Projections, and Demand Outlook 2024-2030-ABB Ltd,GE Grid Solutions,Schneider Electric
Global Twin-Screw Pumps Market Insights - Industry Share, Sales Projections, and …
Twin-Screw Pumps is a displacement pump consisting of a casing containing two parallel screws with intermeshing threads fitted to prevent backward movement of fluid The global Twin-Screw Pumps market was valued at US$ 503 million in 2023 and is anticipated to reach US$ 629 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030. The top five global producers of twin-screw pumps are Colfax, ITT Bornemann, Flowserve, SPX Flow
Global Strain Gauge Sensors Market Insights - Industry Share, Sales Projections, and Demand Outlook 2024-2030-Kohler,Zurn Industries,Western Pottery
Global Strain Gauge Sensors Market Insights - Industry Share, Sales Projections, …
A strain gauge (or strain gage) is a sensor whose resistance varies with applied force; it converts force, pressure, tension, weight, etc., into a change in electrical resistance which can then be measured. When external forces are applied to a stationary object, stress and strain are the result. Stress is defined as the object"s internal Strain Gauge forces, and strain is defined as the displacement and deformation that occur. The global
Global Automatic Soap Dispensers Market Insights - Industry Share, Sales Projections, and Demand Outlook 2024-2030-Colfax,ITT Bornemann,Flowserve
Global Automatic Soap Dispensers Market Insights - Industry Share, Sales Project …
Automatic soap dispensers (also known as touchless or no-touch soap dispensers) dispense a controlled amount of soap solution (or a similar liquid such as a hand sanitizer). They are often used in conjunction with automatic faucets in public restrooms. They function to conserve the amount of soap used and stem infectious disease transmission. The global Automatic Soap Dispensers market was valued at US$ million in 2023 and is anticipated to reach

All 5 Releases


More Releases for Dermatophytic

Call for Automation to Drive the Dermatophytic Onychomycosis Therapeutics Market
Advancements in medicine, diagnosis of varieties of illnesses, and increasing elder population at an unprecedented rate have resulted in high demand for novel drugs and therapies for dermatophytic onychomycosis treatment. In 2021, the dermatophytic onychomycosis therapeutics market was valued at nearly US$ 5.5 Bn, and is set to experience a 6.5% CAGR over the forecast period (2022-2031). Presence and availability of a large clinical pipeline with reference to therapeutic approaches based
Dermatophytic Onychomycosis Therapeutics (DOT) Market 2022 | Detailed Report
The research reports on “Dermatophytic Onychomycosis Therapeutics (DOT) Market” report gives detailed overview of factors that affect global business scope. Dermatophytic Onychomycosis Therapeutics (DOT) Market report shows the latest market insights with upcoming trends and breakdowns of products and services. This report provides statistics on the market situation, size, regions and growth factors. An exclusive data offered in this report is collected by research and industry experts team. Download FREE Sample
Dermatophytic Onychomycosis Therapeutics (DOT) Market
Market growth is primarily driven by factors such as increase in the prevalence of fungal toe nail infections in the U.S. and Canada, and rising per capita healthcare expenditure across the globe. Easy application of nail paints is also expected to drive demand for dermatophytic onychomycosis drugs. However, adverse effects associated with anti-fungal drugs and lack of awareness about dermatophytic onychomycosis in Asia Pacific, Middle East and Africa, and Latin
Dermatophytic Onychomycosis Market Expected to Witness a Sustainable Growth
According to a new report published by Allied Market Research, titled, " Dermatophytic Onychomycosis Market by Product (Nail Paint and Tablet), Route of Administration (Topical and Oral Therapy), and End User (Hospitals, Dermatology & Podiatry Clinics, Independent Pharmacies, Mail Order Pharmacies, and Drug Stores) - Global Opportunity Analysis and Industry Forecast, 2020-2027". The global market size of Dermatophytic Onychomycosis market is $XX million in 2019 with XX CAGR, and it is
Dermatophytic Onychomycosis Market Poised to Rake US$ 4,706.3 Mn by 2021
Key players of the global dermatophytic onychomycosis therapeutics market include Galderma S.A., Valeant Pharmaceuticals International Inc., Novartis AG, Pfizer Inc., Janssen Pharmaceuticals, and others. Leading companies in this market collaborate with healthcare solutions and services providers in order to advance operational efficiencies and provide improved patient care. Persistence Market Research (PMR) delivers key insights on the global dermatophytic onychomycosis therapeutics Market in its latest report titled “Global Market Study on Dermatophytic
Dermatophytic Onychomycosis Market : Topical segment to account 70% share
The global dermatophytic onychomycosis therapeutics market is anticipated to expand at a healthy CAGR during the forecast period. By product type, the market is segmented into Nail paint and tablet, which is again sub-divided into prescription (Rx) and over-the-counter (OTC) sub segments. The nail paint segment is expected to contribute a maximum share to the global dermatophytic onychomycosis therapeutics market and expand at the fastest CAGR of 8.3% during the